US Stock MarketDetailed Quotes
ARWR Arrowhead Pharmaceuticals
- 26.150
- +5.100+24.23%
Close Nov 27 16:00 ET
- 26.600
- +0.450+1.72%
Post 19:53 ET
3.25BMarket Cap-5230P/E (TTM)
26.620High22.250Low6.69MVolume22.370Open21.050Pre Close168.25MTurnover6.06%Turnover RatioLossP/E (Static)124.43MShares39.83052wk High17.55P/B2.89BFloat Cap17.05052wk Low--Dividend TTM110.53MShs Float162.500Historical High--Div YieldTTM20.76%Amplitude1.200Historical Low25.139Avg Price1Lot Size
About Arrowhead Pharmaceuticals Company
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Company Profile
SymbolARWR
Company NameArrowhead Pharmaceuticals
Listing DateJun 16, 1993
Issue Price3.60
Founded1989
CEODr. Christopher Anzalone,PhD
MarketNASDAQ
Employees525
Fiscal Year Ends09-30
Address177 East Colorado Boulevard,Suite 700
CityPasadena
ProvinceCalifornia
CountryUnited States of America
Zip Code91105
Phone1-626-304-3400
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Anzalone,PhD
- Director, Chief Executive Officer and President
- 9.92M
- Patrick C. O'Brien
- Chief Operating Officer, General Counsel, Chief Compliance Officer and Corporate Secretary
- 3.31M
- Tracie Oliver
- Chief Commercial Officer
- --
- Kenneth Myszkowski
- Chief Financial Officer and Principal Accounting Officer
- 3.12M
- Dr. Douglass Given, PhD
- Chairman of the Board
- 474.60K
- Dr. Michael S. Perry, PhD
- Independent Director
- 459.60K
- William D. Waddill
- Independent Director
- 469.60K
- Dr. Mauro Ferrari
- Independent Director
- 459.60K
- Dr. Adeoye Olukotun, M.D.,M.P.H.
- Independent Director
- 459.60K
- Victoria Vakiener
- Independent Director
- 452.10K
- Dr. Hongbo Lu, PhD
- Independent Director
- --
- Dr. Bruce D. Given, M.D.
- Chief Medical Scientist
- --
- James Hamilton
- Chief of Discovery and Translational Medicine
- 3.05M
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
